Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
Outset Medical Inc (NASDAQ: OM) closed the day trading at $2.85 up 12.65% from the previous closing price of $2.53. In other words, the price has increased by $12.65 from its previous closing price. On the day, 0.96 million shares were traded. OM stock price reached its highest trading level at $2.93 during the session, while it also had its lowest trading level at $2.51.
Ratios:
For a better understanding of OM, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 4.37 and its Current Ratio is at 5.26. In the meantime, Its Debt-to-Equity ratio is 1.11 whereas as Long-Term Debt/Eq ratio is at 1.10.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, BTIG Research on April 08, 2024, initiated with a Buy rating and assigned the stock a target price of $6.
On April 05, 2024, CL King Upgraded its rating to Buy which previously was Neutral but kept the price unchanged to $6.
RBC Capital Mkts Downgraded its Outperform to Sector Perform on January 12, 2024, whereas the target price for the stock was revised from $14 to $6.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 15 ’24 when Nash Marc sold 2,391 shares for $2.13 per share. The transaction valued at 5,093 led to the insider holds 242,510 shares of the business.
Ahmed Nabeel sold 1,584 shares of OM for $4,990 on Mar 01 ’24. The Chief Financial Officer now owns 322,877 shares after completing the transaction at $3.15 per share. On Feb 15 ’24, another insider, Trigg Leslie, who serves as the Chair and CEO of the company, sold 5,320 shares for $3.57 each. As a result, the insider received 18,992 and left with 833,091 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, OM now has a Market Capitalization of 147351264 and an Enterprise Value of 76805200. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.10 while its Price-to-Book (P/B) ratio in mrq is 1.17. Its current Enterprise Value per Revenue stands at 0.589 whereas that against EBITDA is -0.468.
Stock Price History:
The Beta on a monthly basis for OM is 1.84, which has changed by -0.8639618 over the last 52 weeks, in comparison to a change of 0.23568535 over the same period for the S&P500. Over the past 52 weeks, OM has reached a high of $24.13, while it has fallen to a 52-week low of $1.92. The 50-Day Moving Average of the stock is 12.67%, while the 200-Day Moving Average is calculated to be -59.59%.
Shares Statistics:
Over the past 3-months, OM traded about 967.62K shares per day on average, while over the past 10 days, OM traded about 712820 shares per day. A total of 50.32M shares are outstanding, with a floating share count of 46.36M. Insiders hold about 8.20% of the company’s shares, while institutions hold 107.64% stake in the company. Shares short for OM as of 1713139200 were 8582236 with a Short Ratio of 8.87, compared to 1710460800 on 8516387. Therefore, it implies a Short% of Shares Outstanding of 8582236 and a Short% of Float of 19.459999.
Earnings Estimates
Investors are keenly observing as 7.0 analysts analyze and rate the current performance of Outset Medical Inc (OM) in the stock market.On average, analysts expect EPS of -$0.55 for the current quarter, with a high estimate of -$0.44 and a low estimate of -$0.62, while EPS last year was -$0.72. The consensus estimate for the next quarter is -$0.53, with high estimates of -$0.46 and low estimates of -$0.59.
Analysts are recommending an EPS of between -$1.95 and -$2.18 for the fiscal current year, implying an average EPS of -$2.07. EPS for the following year is -$1.8, with 7.0 analysts recommending between -$1.65 and -$1.99.
Revenue Estimates
7 analysts predict $30.34M in revenue for the current quarter. It ranges from a high estimate of $31M to a low estimate of $29.6M. As of the current estimate, Outset Medical Inc’s year-ago sales were $31.76MFor the next quarter, 7 analysts are estimating revenue of $33.62M. There is a high estimate of $35.8M for the next quarter, whereas the lowest estimate is $32M.
A total of 8 analysts have provided revenue estimates for OM’s current fiscal year. The highest revenue estimate was $150.1M, while the lowest revenue estimate was $145.73M, resulting in an average revenue estimate of $148.17M. In the same quarter a year ago, actual revenue was $130.38MBased on 8 analysts’ estimates, the company’s revenue will be $174.16M in the next fiscal year. The high estimate is $179M and the low estimate is $165.7M.
